Similasan Wechseljahr-Beschwerden
Similasan Wechseljahr-Beschwerden is a medicine authorised by Swissmedic under authorisation number 53358. The authorisation holder is Similasan AG. The medicinal product code is Homeopathic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 24 February 1997 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 53358 |
|---|---|
| Name | Similasan Wechseljahr-Beschwerden |
| Full name | Similasan Wechseljahr-Beschwerden, Globuli |
| Authorisation holder | Similasan AG |
| Medicinal product code | Homeopathic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 24 February 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Similasan Wechseljahr-Beschwerden, Globuli | D | 24 February 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 40 | 15 | g | - | 20.01.1. | D |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Similasan Wechseljahr-Beschwerden authorised in Switzerland?
Yes. Similasan Wechseljahr-Beschwerden is authorised by Swissmedic under authorisation number 53358, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Similasan Wechseljahr-Beschwerden have?
Similasan Wechseljahr-Beschwerden is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Similasan Wechseljahr-Beschwerden?
The authorisation holder is Similasan AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.